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Abstract
Purpose: To analyze the impact of mobile electronic devices (MEDs) and apps in the daily clinical activity of young radiation or
clinical oncologists in 5 Western European countries (Italy, Germany, Spain, Portugal, and Denmark). Methods: A web-based
questionnaire was sent to 462 young (40 years) members of the national radiation or clinical oncology associations of the
countries involved in the study. The 15 items investigated diffusion of MEDs (smartphones and/or tablets), their impact on daily
clinical activity, and the differences perceived by participants along time. Results: A total of 386 (83.5%) of the 462 correctly filled
questionnaires were statistically evaluated. Up to 65% of respondents declared to use an electronic device during their clinical
activity. Conversely, 72% considered low to moderate impact of smartphones/tables on their daily practice. The daily use sig-
nificantly increased from 2009 to 2012: users reporting a use 6 times/d raised from 5% to 39.9%. Professional needs fulfillment
was declared by less than 68% of respondents and compliance to apps indications by 66%. Significant differences were seen among
the countries, in particular concerning the feeling of usefulness of MEDs in the daily clinical life. The perception of the need of a
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comprehensive Web site containing a variety of applications (apps) for clinical use significantly differed among countries in 2009,
while it was comparable in 2012. Conclusions: This survey showed a large diffusion of MEDs in young professionals working in
radiation oncology. Looking at these data, it is important to verify the consistency of information found within apps, in order to
avoid potential errors eventually detrimental for patients. ‘‘Quality assurance’’ criteria should be specifically developed for medical
apps and a comprehensive Web site gathering all reliable applications and tools might be useful for daily clinical practice.
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Introduction
The field of clinical oncology rapidly evolved over the last
decades and several technological, medical, and biological
innovations changed the daily practice of clinical oncolo-
gists.1-3 Thus, a continuous effort to optimize medical educa-
tion and update skills and knowledge is strongly demanded.
National and international congresses represent a helpful pos-
sibility, but they are often time and resource consuming.
Moreover, some important geographical and logistic issues
potentially limit a widespread participation, in particular for
young professionals. Nevertheless, it is a rather frequent sit-
uation for physicians to examinate patients having a previous
informative background regarding their health conditions
and disease, obtained from ‘‘official’’ or ‘‘unofficial’’
cancer-related Web sites.4-6 In recent years, tablets and smart-
phones became widely diffused worldwide, potentially over-
coming the limits of a slow internet connection or the
impossibility to easily access a personal computer to obtain
medical information. These mobile electronic devices
(MEDs) and their available different tools represent a very
interesting way to overcome the aforementioned limitations.
Indeed, they could be promptly consulted during the daily
clinical activity. Moreover, several dedicated softwares
(apps) are available online and could be easily downloaded
and installed, usually for free: thus, MEDs became accessible
sources of information and education for radiation oncolo-
gists. Given this technological and social background, those
MEDs are now an important tool in the daily clinical practice
of radiation oncologists. It is worth noting that some differ-
ences in the diffusion and utilization of MEDs could be influ-
enced by the ‘‘technological level’’ of a country and the
‘‘technological habits’’ of the physicians. One of the major
aims of the Italian Association of Radiation Oncology
(AIRO)—Young Members Working Group (AIRO Giovani)
is the conduction of studies and activities investigating dif-
ferent issues related to young members of the society.7-13 The
Pocketable Electronic Devices in Radiation Oncology
(PEDRO) project is an international, web-based survey inves-
tigating the impact of MEDs on the clinical practice of young
radiation oncologists. As a first step, we previously reported on
exclusive Italian data.11 Thereafter, we performed a compara-
tive analysis with the data of other European young national
radiotherapy societies involved in the project (Spain, Portu-
gal, Denmark, and Germany). The aim of this study is to
report definitive results of the PEDRO survey.
Material and Methods
A self-produced 15-item-based, nonvalidated, questionnaire
was designed by a specific task force of AIRO Giovani. The
questionnaire was subsequently evaluated by 2 external
reviewers and modified according to their suggestions in terms
of content, face validity, wording, and flow. Finally, 3 ques-
tions allowed open text answers and 11 questions presented
multiple choice items. The survey was entirely conducted dur-
ing 2013. Questions number 6 to 9 and 15 (referred to the years
2009 and 2012) should be intended as a report of participants’
perception regarding their habits in using MEDs during their
clinical activity in the cited years. Representatives from the young
sections of 5 European scientific societies devoted to radiation
oncology were contacted and asked to diffuse the survey, namely,
AIRO, German Society for Radiotherapy and Oncology, The
Danish Association of Young Oncologists, Spanish Association
of Radiotherapy and Oncology, and Portuguese Society of Radio-
therapy and Oncology. Their databases were consulted in order to
target young members (<40 years; both young specialist and res-
idents). A total of 462 young professionals were identified and
reached via e-mail for participation to the PEDRO International
project (anonymity of the survey was addressed in the presenta-
tion letter). The survey was conducted online, using the Internet-
based Survey-Monkey platform (www.surveymonkey.com), and
completion took about 10 minutes. The survey was active from
September to December 2013. Twice a month, an e-mail reminder
was send to all the so-identified participants. The completed
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questionnaires were collected and anonymously analyzed during
February and March 2014.
Statistical Analysis
In order to provide a glimpse into eventual differences occurring
during time in terms of frequency of daily use and utility percep-
tion of MEDs, a subgroup analysis was performed according to
the year considered (2009 and 2012). Two approaches were
employed. A transversal approach investigating eventual differ-
ences occurring among different scientific society members dur-
ing 2009 and during 2012, either on the whole sample with
‘‘society’’ as a variable (5 variables overall) and on a specific
sample for each society compared to AIRO data set as reference
(2 variables). A longitudinal approach investigating eventual dif-
ferences occurring within the members of the same society
between 2009 and 2012 was also performed. Pearson chi-
square (PCS) tests for independence (1 or 4 degree of freedom
at significance level a ¼ .05 for 2 or 5 variable analyses, respec-
tively) were performed using cross-tabulations for items 6 and 9
and for items 14 and 15 (see Table 1 for the items). The level of
statistical significance for PCS was set to3.84 and9.49 for 1
and 4 degrees of freedom analyses, respectively. The investiga-
tion evaluated whether the dichotomous variable society (for year
2009 and 2012, respectively) and ‘‘year’’ (2009 vs 2012) might be
associated with the frequency distributions of the analyzed events
considered as categorical variables in our sample (high vs low use
level: 6-10/11-15/16 vs 0-1/2-5; high vs low level of utility
perception: yes/probably yes vs no/probably not). The events
we considered were mutually exclusive and had a total probability
of 1. A test of goodness of fit was performed (assessing whether
the observed frequency distribution differed from a theoretical
distribution). The open text answers were also analyzed and clas-
sified following a categorical affinity approach. Descriptive and
quantitative statistical analyses were performed with SPSS Sta-
tistics Software version 19.0 (IBM, Armonk, New York).
Results
Descriptive Statistics
A total of 386 (83.5%) of the 462 questionnaires were com-
pletely filled in and consequently taken into account for the
present analysis; those partially completed were automatically
disregarded by the electronic platform, thus avoiding selection
bias. The number of respondents strongly varied according to
country from 158 for Italy to 26 for Portugal (reflecting differ-
ences in the total number of young radiation oncologists in the
participant countries). The distribution between residents and
specialists was quite similar for Germany and Portugal, in favor
of specialists for Spain and Italy and in favor of residents for
Denmark. Overall mean age of the participants was 32.8 years.
Mean age ranged from 31.5 (Portugal) to 35.6 (Germany) (see
Table 1 for details).
Data About MEDs Diffusion in the Daily Clinical Practice
The overall reported use of MEDs (tablet and/or smartphone)
among the considered countries was 65.1%. In Italy, almost
58% of respondents declared to use a tablet in daily clinical
activity, while up to 17% used both a tablet and a smartphone
(Figure 1A). For Germany, 36% reported to use a smartphone
(10.1% both a smartphone and a tablet; Figure 2A). For
Denmark, 52.5% used a smartphone (Figure 3A). For Spain,
up to 50% declared to use a smartphone (Figure 4A), while for
Portugal, 46.2% used a smartphone, 11.5% a tablet, and 19.2%
both (Figure 5A). Main apps by category employed during
daily clinical activity included cancer staging and treatment
(Italy, Germany, Spain, and Portugal), apps for bibliographic
researches (Italy, Denmark, Spain, and Portugal), radiobiolo-
gical (all the considered countries), and general medicine apps
(Germany and Denmark; Figures 6D and 7). Main apps
employed by type included guidelines, radiobiological calcu-
lators, citation databases, and drug vademecum (Figures 6B
and 8). Interestingly, main apps that respondents would desire
to be created and shared online included oncological guide-
lines, contouring tools, radiotherapy guidelines, and apps
allowing for external access to the informatics hospital system
(Figure 6E).
Data About Perceived MED Usefulness in the Daily
Clinical Practice
The real impact of these devices during routine activity is still
considered low–moderate for Italy (82.2%), Germany (87.2%),
Denmark (91.8%), Spain, and Portugal (65.4%; Figures 1B,
;2B, ;3B, ;4B, and ;5B). Despite the frequent use of electronic
devices, the fulfillment of professional needs and requirements
is never or occasionally achieved for 85.5% of respondents for
Italy (Figure 1C), 76.4% for Germany (Figure 2C), and 73.8%
for Denmark (Figure 3C). Spain and Portugal had a frequent or
Table 1. Features of the Population.
Italy Germany Denmark Spain Portugal
Sample, N 158 89 61 52 26
Age, years
Average 33.9 33.0 32.1 34.7 31.5
Min 26.9 25.0 26.0 28.0 27.0
Max 40.0 39.0 39.0 41.0 41.0
Specialists,
N (%)
108 (68.35) 42 (47.2) 8 (13) 43 (83) 15 (57.7)
Age, years
Average 35.6 35.5 37.9 35.3 33.7
Min 30.0 30.0 36.0 29.0 30.0
Max 40.0 39.0 39.0 41.0 41.0
Residents, N
(%)
50 (31.65) 47 (52.8) 53 (87) 9 (17) 11 (42.3)
Age, years
Average 30.5 30.8 31.2 32.1 28.5
Min 26.0 25.0 26.0 28.0 27.0
Max 40.0 36.0 38.0 40.0 31.0
Abbreviations: max, maximum; min, minimum.
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Figure 2. Impact of apps by country—Germany.
Figure 1. Impact of apps by country—Italy.
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Figure 3. Impact of apps by country—Denmark.
Figure 4. Impact of apps by country—Spain.
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constant fulfillment for 55.7% and 53.8% of respondents
(Figures 4C and 5C). Compliance to the indications obtained
from apps is declared by 34.2% of participants for Italy (Figure
1D), 21.4% for Germany (Figure 2D), and 26.2% for Denmark
(Figure 3D). Conversely, these results rose up to 57.7% for
Spain (Figure 4D) and Portugal (Figure 5D).
Data About the Time Trend of MED Utilization in the
Daily Clinical Practice
The daily use of electronic devices/apps was significantly dif-
ferent among the different countries on an overall basis both in
2009 (PCS ¼ 10.859) and 2012 (PCS ¼ 31.299). The magni-
tude of this difference was found higher in 2012. Having Italy
as a reference, statistically significant differences in terms of
the daily use were found in 2009 for Germany (PCS ¼ 7.780)
and Denmark (PCS ¼ 4.786) with less utilization in Germany
and Denmark. In 2012 (still with Italy as comparison), signif-
icant differences were found with Spain (PCS ¼ 8.772), which
had superior use, Germany (PCS ¼ 5.793), and Denmark
(PCS ¼ 6.692), which continued to use MEDs less frequently.
Regarding the variations in utilization between 2009 and
2012 within the same country, it was found that in Italy the
proportion of physicians with a high daily use significantly
increased from 5% to 39.9% (PCS ¼ 17.726). In 2012, up to
12.7% of Italian respondents used apps more than 10 times/d
(Figure 6A). Germany showed a significant increase from 5.6%
to 24.7% (PCS ¼ 12.618), with 9% reporting to use apps
>10 times/d. Also Denmark presented a significant increase
from 6.5% to 21.3% (PCS ¼ 5.536), with 4.9% of respondents
reporting to use apps >10 times/d. Spain had a statistically
significant increase from 13.4% to 63.5% (PCS¼ 27.463), with
30.8% reporting to use apps >10 times/d, while Portugal raised
up from 15.3% to 53.8% (PCS ¼ 8.497), reporting to use apps
>10 times/d (Figure 9A-D).
The Issue of a Web Site Collecting the Available Apps:
The Perception of the Participants
The perception of the need for a comprehensive Web site con-
taining a variety of apps for clinical use significantly differed
among countries in 2009 (PCS ¼ 16.331), while it was
Figure 5. Impact of apps by country—Portugal.
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comparable in 2012 (PCS ¼ 4.237; no statistically significant
difference). With Italy as a reference, in 2009, the only signif-
icant difference was found with Spain (PCS ¼ 13.193), which
had an inferior perception of the utility of such kind of Web
site. In 2012, no difference could be found among Italy and
other countries. Regarding the differences in the perception of
the need for a comprehensive Web site between 2009 and 2012
within the same country, Italy and Germany had highly signif-
icant increases (PCS ¼ 54.205 and 41.978, respectively), with
up to 97.5% and 96.6% of respondents desiring it in 2012
(Figures 6C and 8A). Spain (PCS ¼ 27.463), Portugal
(PCS ¼ 8.497), and Denmark (PCS¼ 5.536) showed lower, but
still significant increase with 100% of physicians desiring it in
2012 (Figure 8B-D). In general, the need for a comprehensive
Web site gathering together all reliable apps and tools was found
to be highly demanded in all countries in recent years (Figures 8
and 10).
Discussion
To the best of our knowledge, the PEDRO project is the first
study aiming at the analysis of the diffusion and impact of
MEDs among young radiation oncologists in Western Europe.
The high response rate of 83.5% renders these data a quite
realistic picture of the young radiation oncologist’s current
perception on the role, diffusion, and impact of these devices
during daily clinical practice. In our opinion, several charac-
teristics of the present study should be underlined. The survey
was anonymously filled in online, and the incompletely filled
in questionnaires were automatically rejected by the platform,
avoiding selection bias. The statistical method, which was
used, allows an ‘‘intracountry’’ analysis (showing eventual dif-
ferences between 2009 and 2012) but also an ‘‘intercountries’’
analysis (showing differences between the participating coun-
tries). Finally, nonrespondents characteristics were collected
Figure 6. Habits in apps utilization—Italy (reference data).
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and found similar to those of attending patients (data not
shown). Our results suggest a rather important impact of MEDs
in the daily clinical practice of respondents: Overall, 65% of
physicians declared to use a smartphone and/or a tablet during
their clinical activity, even if this use was much lower in Ger-
many compared to other countries (49.4%). One of the most
relevant results of the PEDRO survey regards the perceived
impact of MEDs in the routine activity. Indeed, more than
80% of Italian, German, and Danish participants consider it
as low–moderate. This means that young radiation oncologists
frequently use the apps, but they do not consider them essential
or at least have a critical approach toward their integration
within the clinical decision-making process. Easy access to a
quick and friendly application may lead to a frequent consulta-
tion during working activities; conversely, the application of
the suggestion and recommendation implies a trustful process
that takes into account the reliability of the electronic tool.
Thus, there may be only a partial correspondence between
consultation and practical repercussion rates. This finding is
divergent to the constant use increase detected in all countries
over time (2009-2012). Conversely, Spanish and Portuguese
participants showed a major impact of MEDs, as one-third of
them consider them as essential. Moreover, most of respon-
dents reported a low level of satisfaction toward the congruity
of indications provided by the employed apps, as the fulfill-
ment of professional needs and requirements was never or
occasionally achieved for 73.8% to 85.5% of respondents in
Italy, Germany, and Denmark (Figures 1C, 2C, and 3C). Con-
sistent with previous findings, Spanish and Portuguese physi-
cians showed a completely different trend, reporting frequent
or constant fulfillment for more than 50% of respondents (Fig-
ures 4C and 5C). Some hypotheses may be supposed: residents
(44% of participants) are probably still incompletely autono-
mous in the clinical decision making, and the presence of an
institutional duty of a decisional filter performed by a tutorial
figure could mitigate the influence of MEDs. However, the
explanation for the ‘‘frequent referral/low real utilization’’
dichotomy for the Italian subgroup could not be applied to the
Spanish group, which was principally constituted by young
specialists. For specialists (56% of respondents), this diverging
profile could be explained with the clinical experience and
professional maturity leading to a critical interpretation of sug-
gestions derived from apps and MEDs. Looking at the trend of
utilization over time, it shows an overall ‘‘high daily use’’
Figure 7. Most used apps by country.2
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increase from 2009 to 2012. The daily impact of MEDs is
quickly raising both in general population and in the profes-
sional life of physicians. It has been reported as increasing from
44% (2010) to 81% (2012) for smartphones and from 30%
(2011) to over 72% (2013) for tablets, respectively.14,15 Our
study also confirms trends recently published within wide-
spread and popular newspapers: an article in the Wall Street
Journal showed that in 2011 up to 72% of all medical doctors
in the United States own a smartphone and up to 95% of them
do usually download apps.16 In this context, the discipline of
Radiation Oncology is much more influenced by the important
evolving relationship between health care and technology, as
clinical, technical, and computational aspects are clearly more
interconnected. Thus, radiation oncologists could probably
consider the role of MEDs very appealing, as they could be
in their opinion a potential means to improve cancer care. The
MEDs allow rapid access to the most updated information
(apps, podcasts, reference texts, protocols, and recent research)
and to the clinical guidelines endorsed by the most important
radiation and clinical oncology societies. Moreover, several
available apps strongly simplify the bedside use of medical
equations (eg, Biologically effective dose (BED) calculation,
scores, tumor staging, risk prediction, etc). We analyzed the
use and diffusion of MED among young radiation oncologists,
but it is worthwhile to note that a consistent literature has also
been produced studying the potential impact of MED on edu-
cational processes of medical students and in the informational
background of patients.17-23 In this context, the importance of a
correct knowledge of the clinical use of apps is strongly needed
and should be underlined.23-26 Indeed, the important potential
advantages could be mitigated by some critical issues that must
be strictly taken into account. Approaching MED and apps, the
first question should be who are the providers and what is their
reputation? One of the indices of the apps quality should be, in
our opinion, the possibility to correctly and easily identify the
name of the provider and the overall evaluation of the apps
given in the user comments. O’Neill et al. analyzed 68 medical
apps addressing issues related to colorectal cancer, assessing
the levels of medical professional involvement in their design
and content.27 Only 29% of colorectal apps presented customer
satisfaction ratings and only 32% declared medical profes-
sional involvement in their development or content. The
authors concluded underlining the need for a better control and
regulation of app content. Another recent study by Rodrigues
Figure 8. Perceived usefulness of a Web site containing apps for clinical and radiation oncology.
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et al. analyzed 321 radiology-related smartphone applica-
tions.28 Finally, despite their many potential benefits, the med-
ical involvement in their contents and design was not always
clearly identifiable. Finally, also these authors underlined the
need for well-established measures to ensure apps accuracy.
Van Velsen et al. originally underlined that one of the major
limitations is the growing number of available apps: this over-
load makes it difficult for medical professionals (and citizens)
to find the tools more appropriate to a given situation.29 More-
over, the authors consider that information and features are
fragmented over too many apps, thereby limiting their useful-
ness. Bender et al. reported in a recent review a lack of scien-
tific data supporting the use of cancer-related apps
scientifically supported data.30 In their review, authors report
that only 9.4% of the available apps are affiliated with a uni-
versity or a medical institution. Finally, also these authors con-
cluded that there is a need for a ‘‘white list’’ of scientifically
recommended mobile health apps. We strongly share the posi-
tions of Van Velsen and Bender. In our opinion, it is time for a
‘‘joint venture’’ between the providers of medical information
and the open source movement, aiming at a standardization of
medical information formats and contents, preventing the risk
of overload and improving the quality of the apps, and their
impact on health care quality. We also support the creation of a
Quality Assurance program, allowing also a clear definition of
sources of information (eg, links to published, indexed articles,
and/or to official Web sites). Last but not least, we would
strongly underline that the specific clinical case and the per-
sonal clinical experience of the health care provider are much
more important than information obtained by a MED, which
should be considered as useful tools supporting, but not repla-
cing clinical evaluations and knowledge. Indeed, clinical deci-
sion making should always remain an articulate and thoughtful
process taking into account medical, technical, logistic, and
human aspects. National and international scientific societies
may play an important role in testing and verifying the correct-
ness of the information provided by MED, endorsing, and cer-
tifying those considered valuable and reliable.
Conclusions
The PEDRO project confirmed the constantly increasing trend
of utilization of clinical resources via smartphones and tablets.
It is desirable to achieve a critical use of apps and mobile
Figure 9. Daily use by country.
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technology to potentially optimize medical information and
care processes. Security and reliability of apps remain impor-
tant but actually unsolved issues, as well as the quality of the
electronic resource, which should be checked before the adop-
tion of the information obtained via MED in the clinical
decision-making processes.
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3. Popescu RA, Schäfer R, Califano R, et al. The current and future
role of the medical oncologist in the professional care for cancer
patients: a position paper by the European Society for Medical
Oncology (ESMO). Ann Oncol. 2014;25(1):9-15. doi:10.1093/
annonc/mdt522. Erratum in: Ann Oncol. 2014;25(4):916.
4. Katz JE, Roberge D, Coulombe G. The cancer patient’s use and
appreciation of the internet and other modern means of commu-
nication. Technol Cancer Res Treat. 2014;13(5):477-484. doi:10.
7785/tcrtexpress.2013.600267.
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